^Lemke, T.L., Williams, D.A., Roche, V.T., & Zito, S.W., 2012. Foye's Principles of Medicinal Chemistry. 7th ed. Baltimore, MD: Lippincott Williams & Wilkins, p. 605.
^Healy, D. (2004). Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression. New York: New York University Press, p. 23.
^Beaumont, G., & Healy, D. (1993). The place of clomipramine in the development of psychopharmacology. Journal of Psychopharmacology, 7, 383–393.
^Pichot, P. (1996). The discovery of chlorpromazine and the place of psychopharmacology in the history of psychiatry. The Psychopharmacologists (Vol. 1, pp. 1–21). London, England: Chapman & Hall.
^абMillan, M. J.; Gobert, A.; F, Lejeune; et al. (2001). „S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine”.The Journal of Pharmacology and Experimental Therapeutics.298 (2): 565—80.PMID11454918.CS1 одржавање: Експлицитна употреба et al. (веза)
^Monsma FJ, Shen Y, Ward RP, Hamblin MW, Sibley DR (1993). „Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs”.Molecular Pharmacology.43 (3): 320—7.PMID7680751.
^Toll, L.; Berzetei-Gurske, I. P.; Polgar, W. E.; et al. (1998). „Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications”.NIDA Research Monograph.178: 440—66.PMID9686407.CS1 одржавање: Експлицитна употреба et al. (веза)